Page last updated: 2024-11-03

rabeprazole and Chagas Disease

rabeprazole has been researched along with Chagas Disease in 1 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
García-Torres, I1
De la Mora-De la Mora, I1
López-Velázquez, G1
Cabrera, N1
Flores-López, LA1
Becker, I1
Herrera-López, J1
Hernández, R1
Pérez-Montfort, R1
Enríquez-Flores, S1

Other Studies

1 other study available for rabeprazole and Chagas Disease

ArticleYear
Repurposing of rabeprazole as an anti-
    Journal of enzyme inhibition and medicinal chemistry, 2023, Volume: 38, Issue:1

    Topics: Chagas Disease; Drug Repositioning; Humans; Rabeprazole; Triose-Phosphate Isomerase; Trypanocidal Ag

2023